192 related articles for article (PubMed ID: 1680632)
21. N-Acetylation of paraphenylenediamine in human skin and keratinocytes.
Kawakubo Y; Merk HF; Masaoudi TA; Sieben S; Blömeke B
J Pharmacol Exp Ther; 2000 Jan; 292(1):150-5. PubMed ID: 10604942
[TBL] [Abstract][Full Text] [Related]
22. Testosterone modulation of N-acetylation in mouse kidney.
Smolen TN; Brewer JA; Weber WW
J Pharmacol Exp Ther; 1993 Feb; 264(2):854-8. PubMed ID: 8437129
[TBL] [Abstract][Full Text] [Related]
23. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
Ho CC; Lin TH; Lai YS; Chung JG; Levy GN; Weber WW
Drug Metab Dispos; 1996 Feb; 24(2):137-41. PubMed ID: 8742223
[TBL] [Abstract][Full Text] [Related]
25. Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver.
Hein DW; Hirata M; Glowinski IB; Weber WW
J Pharmacol Exp Ther; 1982 Jan; 220(1):1-7. PubMed ID: 7053406
[TBL] [Abstract][Full Text] [Related]
26. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
[TBL] [Abstract][Full Text] [Related]
27. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
[TBL] [Abstract][Full Text] [Related]
28. Ecogenetic studies of drug acetylation in man and rats.
Dubbels R; Khoory R; Schloot W
Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
[TBL] [Abstract][Full Text] [Related]
29. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
30. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
31. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
[TBL] [Abstract][Full Text] [Related]
32. [Localization of N-acetyltransferases in sinusoidal liver cells. Effect of zymosan on the acetylation of sulfamethazine and isoniazid in the rat and in isolated perfused liver].
Notter D; Roland E
C R Seances Soc Biol Fil; 1978; 172(3):531-3. PubMed ID: 153185
[TBL] [Abstract][Full Text] [Related]
33. Expression of monomorphic and polymorphic N-acetyltransferases in human colon.
Ilett KF; Ingram DM; Carpenter DS; Teitel CH; Lang NP; Kadlubar FF; Minchin RF
Biochem Pharmacol; 1994 Mar; 47(5):914-7. PubMed ID: 8135868
[TBL] [Abstract][Full Text] [Related]
34. An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro.
Hein DW; Hirata M; Weber WW
Pharmacology; 1981; 23(4):203-10. PubMed ID: 6976581
[TBL] [Abstract][Full Text] [Related]
35. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
Mattano SS; Land S; King CM; Weber WW
Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
[TBL] [Abstract][Full Text] [Related]
36. Arylamine N-acetyltransferase activities in human breast cancer tissues.
Geylan YS; Dizbay S; Güray T
Neoplasma; 2001; 48(2):108-11. PubMed ID: 11478689
[TBL] [Abstract][Full Text] [Related]
37. Effects of vitamin C on arylamine N-acetyltransferase activity in human liver tumor cells.
Wu LT; Chung JG
Anticancer Res; 1998; 18(5A):3481-6. PubMed ID: 9858928
[TBL] [Abstract][Full Text] [Related]
38. N-Acetylation of p-aminobenzoic acid and p-phenylenediamine in primary porcine urinary bladder epithelial cells and in the human urothelial cell line 5637.
Föllmann W; Blaszkewicz M; Behm C; Degen GH; Golka K
J Toxicol Environ Health A; 2012; 75(19-20):1206-15. PubMed ID: 22994574
[TBL] [Abstract][Full Text] [Related]
39. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
Hein DW; Smolen TN; Fox RR; Weber WW
J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
[TBL] [Abstract][Full Text] [Related]
40. Rodent models of the human isoniazid-acetylator polymorphism.
Tannen RH; Weber WW
Drug Metab Dispos; 1979; 7(5):274-9. PubMed ID: 40765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
